Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disorder”

Showing 20 of 0 results

Not applicableStudy completedNCT01784328
What this trial is testing

Peristeen Bowel Irrigation System in Cauda Equina

Who this might be right for
Cauda Equina Syndrome
University of Manitoba 12
Not applicableUnknownNCT02759913
What this trial is testing

Evaluate the Performance of a Diagnostic Test in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Iron Horse Diagnostics, Inc. 300
Not applicableStudy completedNCT05209282
What this trial is testing

Diplegic Cerebral Palsy and Action Observation Training

Who this might be right for
Diplegic Cerebral Palsy
Inonu University 39
Not applicableUnknownNCT05761262
What this trial is testing

SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients

Who this might be right for
Spinal Muscular Atrophy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 91
Not applicableUnknownNCT04953624
What this trial is testing

Appetite and Related Factors in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT04326283
What this trial is testing

Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genuv Inc. 23
Not applicableUnknownNCT05784727
What this trial is testing

Technical Evaluation of Earswitch Phase A

Who this might be right for
Motor Neuron Disease
University of Bath 110
Early research (Phase 1)Study completedNCT01091142
What this trial is testing

Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuraltus Pharmaceuticals, Inc. 56
Not applicableStudy completedNCT02559869
What this trial is testing

Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Massachusetts General Hospital 86
Not applicableEnded earlyNCT07254988
What this trial is testing

Gut Peptides and Bone Remodeling in Children With Neuromuscular Disorders

Who this might be right for
Spinal Muscular Atrophy (SMA)Cerebral Palsy (CP)Duchenne Muscular Dystrophy (DMD)
University of Copenhagen 3
Testing effectiveness (Phase 2)Ended earlyNCT04494256
What this trial is testing

Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

Who this might be right for
Amyotrophic Lateral Sclerosis
Biogen 99
Not applicableStudy completedNCT00011154
What this trial is testing

Exogenous Toxicants and Genetic Susceptibility in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
National Institute of Environmental Health Sciences (NIEHS) 525
Testing effectiveness (Phase 2)UnknownNCT04849065
What this trial is testing

Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 100
Large-scale testing (Phase 3)Looking for participantsNCT04302870
What this trial is testing

Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

Who this might be right for
Motor Neuron Disease, Amyotrophic Lateral Sclerosis
University of Edinburgh 1,150
Large-scale testing (Phase 3)Not Yet RecruitingNCT06391645
What this trial is testing

Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Beijing Tiantan Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT07221669
What this trial is testing

Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

Who this might be right for
Muscular Atrophy, Spinal
Biogen 30
Not applicableStudy completedNCT04813601
What this trial is testing

Rehabilitative Effect of the Use of a Gait Exoskeleton in Patients With Neuromuscular Disease or Cerebral Palsy

Who this might be right for
Neuromuscular DiseasesCerebral PalsySMA II
MarsiBionics 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07813858
What this trial is testing

Colchicine Effect on Amyotrophic Lateral Sclerosis Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
Azienda Ospedaliero-Universitaria di Modena 87
Testing effectiveness (Phase 2)Study completedNCT04569435
What this trial is testing

Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Annexon, Inc. 17
Not applicableStudy completedNCT00339976
What this trial is testing

Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisALS
National Institute of Environmental Health Sciences (NIEHS)
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation